Free Trial

Celcuity (CELC) Competitors

Celcuity logo
$10.80 -0.34 (-3.05%)
Closing price 04:00 PM Eastern
Extended Trading
$10.78 -0.02 (-0.19%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CELC vs. NHC, PACS, TDOC, VRDN, AHCO, CDNA, GRAL, PNTG, AVAH, and CSTL

Should you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Grail (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry.

Celcuity vs.

National HealthCare (NYSE:NHC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

National HealthCare has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500.

56.4% of National HealthCare shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 15.0% of National HealthCare shares are held by company insiders. Comparatively, 15.8% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

National HealthCare has a net margin of 10.03% compared to Celcuity's net margin of 0.00%. National HealthCare's return on equity of 6.87% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
National HealthCare10.03% 6.87% 4.68%
Celcuity N/A -62.66%-39.78%

Celcuity received 338 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 67.79% of users gave Celcuity an outperform vote.

CompanyUnderperformOutperform
National HealthCareOutperform Votes
3
100.00%
Underperform Votes
No Votes
CelcuityOutperform Votes
341
67.79%
Underperform Votes
162
32.21%

National HealthCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National HealthCare$1.30B1.11$66.80M$6.5414.26
CelcuityN/AN/A-$63.78M-$2.81-3.90

In the previous week, Celcuity had 4 more articles in the media than National HealthCare. MarketBeat recorded 6 mentions for Celcuity and 2 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.62 beat Celcuity's score of 1.36 indicating that National HealthCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National HealthCare
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Celcuity
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Celcuity has a consensus target price of $30.17, indicating a potential upside of 175.60%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than National HealthCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National HealthCare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Celcuity
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Summary

National HealthCare and Celcuity tied by winning 9 of the 18 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELC vs. The Competition

MetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$413.20M$2.89B$5.50B$7.96B
Dividend YieldN/A31.29%5.11%4.23%
P/E Ratio-4.1813.0722.6318.55
Price / SalesN/A189.00397.30103.38
Price / CashN/A57.5638.1834.62
Price / Book2.004.696.704.25
Net Income-$63.78M-$22.21M$3.23B$248.27M
7 Day Performance-0.85%-2.34%1.36%1.28%
1 Month Performance17.83%2.61%3.85%3.75%
1 Year Performance-32.85%10.54%15.87%5.31%

Celcuity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELC
Celcuity
2.6347 of 5 stars
$10.80
-3.1%
$30.17
+179.3%
-29.4%$408.66MN/A-4.1440Short Interest ↓
Analyst Revision
Positive News
NHC
National HealthCare
N/A$90.31
-2.0%
N/AN/A$1.40B$1.30B11.3212,400Positive News
PACS
PACS Group
3.3629 of 5 stars
$8.58
-7.3%
$34.00
+296.3%
-61.5%$1.31B$3.56B0.0032,433Positive News
TDOC
Teladoc Health
3.8067 of 5 stars
$6.52
-4.5%
$10.82
+66.0%
-43.8%$1.14B$2.57B-1.135,100Analyst Forecast
News Coverage
VRDN
Viridian Therapeutics
1.2571 of 5 stars
$13.13
flat
$35.70
+171.9%
+2.2%$1.07B$302,000.00-3.0550Upcoming Earnings
News Coverage
Positive News
AHCO
AdaptHealth
3.4489 of 5 stars
$7.33
-5.9%
$13.80
+88.3%
-13.6%$988.58M$3.26B-4.4410,900Upcoming Earnings
CDNA
CareDx
3.4773 of 5 stars
$16.94
-3.9%
$30.33
+79.1%
+117.5%$938.92M$333.79M-6.27740Earnings Report
News Coverage
Gap Down
GRAL
Grail
0.6284 of 5 stars
$26.42
-2.1%
$26.00
-1.6%
N/A$932.55M$125.60M0.001,360Positive News
PNTG
The Pennant Group
3.1681 of 5 stars
$24.50
-6.2%
$34.80
+42.0%
+22.5%$850.69M$695.24M36.035,340Upcoming Earnings
News Coverage
Positive News
AVAH
Aveanna Healthcare
0.9797 of 5 stars
$4.22
-7.0%
$5.00
+18.5%
+104.9%$823.30M$2.02B-12.4133,000Upcoming Earnings
News Coverage
CSTL
Castle Biosciences
3.0659 of 5 stars
$21.14
-1.7%
$38.75
+83.3%
-4.9%$609.78M$332.07M105.71540Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:CELC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners